The full content of Annals is available to subscribers

Subscribe/Learn More  >
Case Reports |

Methotrexate Therapy of Wegener's Granulomatosis

[+] Article, Author, and Disclosure Information

Supported by grants CA05138 and CA08341, U.S. Public Health Service, Washington, D.C. Dr. Bertino is a career development awardee (1-K3-CA8853) of the National Cancer Institute, Bethesda, Md.

▸Requests for reprints should be addressed to Joseph R. Bertino, M.D., Department of Medicine, Yale University School of Medicine, 333 Cedar St., New Haven, Conn. 06510

New Haven, Connecticut

Ann Intern Med. 1971;74(1):74-79. doi:10.7326/0003-4819-74-1-74
Text Size: A A A

Two patients with advanced Wegener's granulomatosis, one with nose, sinus, and skin involvement and the other with pulmonary, renal, and skin involvement, experienced marked improvement with intermittent methotrexate therapy. Initial treatment consisted of weekly intravenous injections of 50 mg. This was subsequently decreased to 15 and 25 mg as a single, weekly oral dose. Responses consisted of marked and rapid subjective relief of symptoms, healing of skin lesions, total clearing of pulmonary infiltrates, and lack of progression of nasal, sinus, and renal lesions. Remission of the disease, for more than 30 and 26 months, respectively, has occurred without evidence of oral or hematologic toxicity of methotrexate.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $40.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.